Nocardiosis in a patient with anti-PD-1-associated colitis treated with infliximab

Eur J Cancer. 2018 Sep:101:284-286. doi: 10.1016/j.ejca.2018.06.014. Epub 2018 Jul 13.

Authors

V Glutsch¹, A Gesierich¹, M Goebeler¹, J Forster², B Schilling³

Affiliations

¹ Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.
² Institute for Hygiene and Microbiology, University of Würzburg, Würzburg, Germany.
³ Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany. Electronic address: schilling_b@ukw.de.

PMID: 30017385
DOI: 10.1016/j.ejca.2018.06.014

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Colitis / chemically induced
Colitis / immunology*
Dermatologic Agents / adverse effects
Dermatologic Agents / immunology
Dermatologic Agents / therapeutic use
Humans
Infliximab / adverse effects
Infliximab / immunology
Infliximab / therapeutic use*
Male
Melanoma / drug therapy*
Melanoma / genetics
Mutation
Nocardia Infections / chemically induced
Nocardia Infections / diagnosis*
Programmed Cell Death 1 Receptor / immunology*
Proto-Oncogene Proteins B-raf / genetics

Substances

Dermatologic Agents
Programmed Cell Death 1 Receptor
Infliximab
BRAF protein, human
Proto-Oncogene Proteins B-raf